Purpose of Review While portal hypertension (PHT) treatment strategies for patients with advanced chronic liver disease (ACLD) are well established, studies on the management of PHTafter orthotopic liver transplantation (OLT) are limited. This is due to the heterogeneous causes of portal hypertension in the OLTsetting..